FI20002525A0 - Tulehduksenvastaisia aineita - Google Patents
Tulehduksenvastaisia aineitaInfo
- Publication number
- FI20002525A0 FI20002525A0 FI20002525A FI20002525A FI20002525A0 FI 20002525 A0 FI20002525 A0 FI 20002525A0 FI 20002525 A FI20002525 A FI 20002525A FI 20002525 A FI20002525 A FI 20002525A FI 20002525 A0 FI20002525 A0 FI 20002525A0
- Authority
- FI
- Finland
- Prior art keywords
- inflammatory substances
- inflammation
- prevention
- treatment
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20002525A FI20002525A (fi) | 2000-11-17 | 2000-11-17 | Tulehduksenvastaisia aineita |
DE60110628T DE60110628T2 (de) | 2000-11-17 | 2001-11-16 | Antiphlogistische mittel |
DK01996384T DK1341539T3 (da) | 2000-11-17 | 2001-11-16 | Antiinflammatoriske midler |
ES01996384T ES2240564T3 (es) | 2000-11-17 | 2001-11-16 | Agentes antinflamatorios. |
JP2002542398A JP4309652B2 (ja) | 2000-11-17 | 2001-11-16 | 抗炎症剤 |
SI200130371T SI1341539T1 (en) | 2000-11-17 | 2001-11-16 | Anti-inflammatory agents |
PT01996384T PT1341539E (pt) | 2000-11-17 | 2001-11-16 | Agentes anti-inflamatorios |
US10/416,713 US6878702B2 (en) | 2000-11-17 | 2001-11-16 | Anti-inflammatory agents |
CA2429109A CA2429109C (en) | 2000-11-17 | 2001-11-16 | Anti-inflammatory agents |
AU2002223708A AU2002223708A1 (en) | 2000-11-17 | 2001-11-16 | Anti-inflammatory agents |
EP01996384A EP1341539B1 (en) | 2000-11-17 | 2001-11-16 | Anti-inflammatory agents |
PCT/FI2001/001000 WO2002040025A1 (en) | 2000-11-17 | 2001-11-16 | Anti-inflammatory agents |
AT01996384T ATE294581T1 (de) | 2000-11-17 | 2001-11-16 | Antiphlogistische mittel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20002525A FI20002525A (fi) | 2000-11-17 | 2000-11-17 | Tulehduksenvastaisia aineita |
Publications (2)
Publication Number | Publication Date |
---|---|
FI20002525A0 true FI20002525A0 (fi) | 2000-11-17 |
FI20002525A FI20002525A (fi) | 2002-05-18 |
Family
ID=8559519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20002525A FI20002525A (fi) | 2000-11-17 | 2000-11-17 | Tulehduksenvastaisia aineita |
Country Status (11)
Country | Link |
---|---|
US (1) | US6878702B2 (fi) |
EP (1) | EP1341539B1 (fi) |
JP (1) | JP4309652B2 (fi) |
AT (1) | ATE294581T1 (fi) |
AU (1) | AU2002223708A1 (fi) |
CA (1) | CA2429109C (fi) |
DE (1) | DE60110628T2 (fi) |
ES (1) | ES2240564T3 (fi) |
FI (1) | FI20002525A (fi) |
PT (1) | PT1341539E (fi) |
WO (1) | WO2002040025A1 (fi) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1612204A4 (en) * | 2003-03-31 | 2007-04-11 | Daiichi Seiyaku Co | HYDRAZONE DERIVATIVE |
DE10337904A1 (de) * | 2003-08-18 | 2005-03-24 | Universität Duisburg-Essen | Substanzen für die Apoptoseregulation, insbesondere Apoptosestimulation |
PT2203439E (pt) | 2007-09-14 | 2011-02-11 | Ortho Mcneil Janssen Pharm | 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridinil-2'- onas 1',3'-dissubstituídas |
AU2020408323A1 (en) | 2019-12-16 | 2022-08-11 | Tenax Therapeutics, Inc. | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF) |
CN112500353B (zh) * | 2020-12-08 | 2022-11-25 | 北京晨光同创医药研究院有限公司 | 一种左西孟旦的前药化合物、制备方法及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8903130D0 (en) * | 1989-02-11 | 1989-03-30 | Orion Yhtymae Oy | Substituted pyridazinones |
US5185332A (en) * | 1989-02-11 | 1993-02-09 | Orion-Yhtyma Oy | Thiadiazines and pharmaceutical compositions thereof as well as method of use |
GB2251615B (en) * | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
US6183948B1 (en) * | 1998-04-15 | 2001-02-06 | Johns Hopkins University | Methods to identify compounds affecting mitochondria |
-
2000
- 2000-11-17 FI FI20002525A patent/FI20002525A/fi unknown
-
2001
- 2001-11-16 JP JP2002542398A patent/JP4309652B2/ja not_active Expired - Fee Related
- 2001-11-16 EP EP01996384A patent/EP1341539B1/en not_active Expired - Lifetime
- 2001-11-16 DE DE60110628T patent/DE60110628T2/de not_active Expired - Lifetime
- 2001-11-16 AU AU2002223708A patent/AU2002223708A1/en not_active Abandoned
- 2001-11-16 AT AT01996384T patent/ATE294581T1/de active
- 2001-11-16 WO PCT/FI2001/001000 patent/WO2002040025A1/en active IP Right Grant
- 2001-11-16 CA CA2429109A patent/CA2429109C/en not_active Expired - Fee Related
- 2001-11-16 US US10/416,713 patent/US6878702B2/en not_active Expired - Fee Related
- 2001-11-16 PT PT01996384T patent/PT1341539E/pt unknown
- 2001-11-16 ES ES01996384T patent/ES2240564T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4309652B2 (ja) | 2009-08-05 |
WO2002040025A1 (en) | 2002-05-23 |
ATE294581T1 (de) | 2005-05-15 |
CA2429109A1 (en) | 2002-05-23 |
EP1341539A1 (en) | 2003-09-10 |
DE60110628T2 (de) | 2006-01-19 |
AU2002223708A1 (en) | 2002-05-27 |
FI20002525A (fi) | 2002-05-18 |
US20040029870A1 (en) | 2004-02-12 |
US6878702B2 (en) | 2005-04-12 |
JP2004520278A (ja) | 2004-07-08 |
DE60110628D1 (de) | 2005-06-09 |
CA2429109C (en) | 2010-02-16 |
EP1341539B1 (en) | 2005-05-04 |
ES2240564T3 (es) | 2005-10-16 |
PT1341539E (pt) | 2005-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE504557T1 (de) | Aspirin-ausgelöste lipidmediatoren | |
DK1206474T3 (da) | Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer | |
CU23029A3 (es) | Analogos sustituidos del benzopirano para el tratamiento de la inflamacion | |
EA200700757A1 (ru) | Замещённые дипиперидиновые антагонисты ccr2 | |
NO20040100L (no) | Nye forbindelser som anti-inflammasjons, immunmodulerende og anti-proliferative midler | |
EA200601648A1 (ru) | Глюкозамин и общие пролекарства глюкозамин/противовоспалительный агент, композиции и способы | |
ATE375334T1 (de) | Harnstoff derivate als entzündungshemmende mittel | |
NO20053042L (no) | Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi. | |
CY1113651T1 (el) | Αντιφλεγμονωδη σκευασματα | |
RS50720B (sr) | 3,11 b-cis-dihidrotetrabenazin za lečenje proliferativne bolesti ili inflamacije | |
ID26055A (id) | Senyawa-senyawa hidroksidifenil eter | |
NO20061792L (no) | Nye triterpenderivater, fremstilling og anvendelse derav | |
CY1109992T1 (el) | Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα | |
PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
PA8586801A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
NO20031648L (no) | Farmasöytiske lösninger av modafinilforbindelser | |
DK1492773T3 (da) | 4-(Heterocyclyl)-benzensulfoximin-forbindelser til behandling af inflammation | |
DK1313740T3 (da) | Prodrugs af imidazopyridinderivater | |
BRPI0415390A (pt) | compostos de pirazinona substituìda para o tratamento da inflamação | |
DE60127131D1 (de) | Tricyclische imidazopyridine | |
FI20002525A0 (fi) | Tulehduksenvastaisia aineita | |
IT1318667B1 (it) | Medicamento antinfiammatorio. | |
EA200300988A1 (ru) | Производные фенил-гетероциклильных эфиров в качестве ингибиторов обратного захвата серотонина | |
PA8525801A1 (es) | Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2 | |
AR024907A1 (es) | Uso de inhibidores de la produccion y/o accion de la il-18 y composiciones farmaceuticas formuladas con dichos inhibidores para el tratamiento demetastasis de tumores. |